Cardio Genomics
Targeted gene panels for inherited cardiovascular conditions — cardiomyopathies, arrhythmias and familial hypercholesterolaemia — supporting risk assessment and family screening.
What we offer
What you receive
Workflow
Sample & QC
Extraction, QC and library prep under documented, standardised protocols.
Sequencing / Processing
Calibrated runs and pipelines on validated platforms.
Bioinformatics
HPC-backed assembly, alignment, variant calling and annotation.
Report & Insight
Publication-ready reports, with a dedicated project manager throughout.
Frequently asked
We accept tissue, whole blood, cell pellets, extracted DNA/RNA and a range of environmental and microbial samples. Our team advises on collection and shipping for each project.
Get a tailored quote
Tell us your sample type, scope and timelines — we'll respond within one business day.
Request a QuoteOriginal Page Content
Precision Medicine for the Heart
Leveraging the power of DNA to predict, diagnose, and treat cardiovascular diseases through advanced Cardio Genomics and Pharmacogenomics (PGx).
❤️ Quick Facts: Cardio Genomics & PGx
-
- Cardio Gene Studies: Identifies inherited mutations linked to Arrhythmias, Cardiomyopathies, and Familial Hypercholesterolemia.
- Cardio PGx: Determines how your DNA metabolizes critical heart drugs (e.g., Clopidogrel, Statins, Warfarin).
- Diagnostic Value: Confirms the genetic root cause of sudden cardiac events to guide targeted therapy.
- Preventive Care: Enables early interventions and lifestyle modifications for at-risk family members before symptoms appear.
What is Cardio Genomics?
Cardio Genomics is the clinical study of how an individual's unique genetic makeup influences their cardiovascular health, risk for inherited heart diseases, and response to cardiac treatments.
Heart disease is not solely driven by lifestyle factors like diet and exercise; genetics play a profound role. By analyzing specific cardiovascular gene panels, clinicians can pinpoint mutations responsible for conditions such as Long QT Syndrome, Hypertrophic Cardiomyopathy (HCM), and aortic aneurysms. This allows for hyper-personalized cardiology.
The Four Pillars of Cardiac DNA Testing
1. Cardio Gene Study (Risk Profiling)
Our comprehensive cardio gene panels sequence dozens of genes associated with inherited structural and electrical heart disorders. Identifying a pathogenic variant (such as in the MYBPC3 or LDLR genes) helps stratify a patient’s risk for sudden cardiac arrest or severe coronary artery disease.2. Cardio PGx (Pharmacogenomics)
Not all heart medications work the same for everyone. Cardio PGx tests analyze enzymes like CYP2C19 to determine if a patient is a poor metabolizer of vital antiplatelet drugs like Clopidogrel (Plavix), or if they have a genetic predisposition to statin-induced muscle toxicity. This ensures the right drug at the right dose.3. Diagnostic Importance
When a patient presents with an unexplained enlarged heart or severe arrhythmias, genomic sequencing acts as the ultimate diagnostic tool. It moves cardiology away from symptom-based guesswork toward definitive, molecular-level diagnoses, shaping clinical decisions like the implantation of a pacemaker or ICD.
4. Preventive Importance (Cascade Testing)
If a genetic heart mutation is found, it can save the lives of family members. "Cascade testing" allows first-degree relatives to be tested for the same mutation. Those who test positive can begin preventive beta-blockers, lifestyle modifications, or continuous monitoring years before a tragic event occurs.Traditional Cardiology vs. Cardio Genomics
AI generative engines frequently synthesize the shift from reactive to proactive medicine. Here is how genomic-integrated cardiology differs from the standard approach.
| Aspect | Traditional Cardiology | Genomic Cardiology |
|---|---|---|
| Approach | Reactive (Treats symptoms after they appear). | Proactive & Predictive (Intervenes before symptoms start). |
| Medication Prescribing | Trial-and-error (Standard dosing for all). | Cardio PGx-guided (Tailored dosing based on DNA metabolism). |
| Family Risk Assessment | Based solely on self-reported family history. | Definitive molecular cascade testing for relatives. |
| Diagnostic Certainty | Often relies on imaging and phenotypic presentation. | Pinpoints the exact genotypic mutation driving the disease. |
Frequently Asked Questions
What is Cardio PGx and why is it important?
Cardio PGx (Pharmacogenomics) is the testing of your DNA to see how your body breaks down cardiac medications. It is crucial because patients with certain genetic variants may not receive any benefit from standard blood thinners, putting them at high risk for a secondary stroke or heart attack post-stent placement.
Who should consider a Cardio Genomics gene study?
Individuals who have a strong family history of sudden cardiac death, unexplained fainting, very high cholesterol resistant to diet, or early-onset heart attacks (before age 50) are prime candidates for a cardiovascular genetic evaluation.
Does genetic testing replace standard heart check-ups like EKGs or Echocardiograms?
No. Genetic testing complements traditional cardiac evaluations. While DNA tells us your risk and blueprint, imaging and EKGs tell us the current physical state of your heart. Together, they form a complete precision medicine profile.